Related Experiment Video
Updated: Jan 12, 2026
Author Spotlight: In Vitro Investigations of Circadian Rhythms in Multicellular Systems
Published on: February 16, 2024
[Chronobiotics as potential geroprotectors.]
1Pitirim Sorokin Syktyvkar State University, Medical Institute, 55 Oktyabrsky pr., Syktyvkar 167000, Russian Federation,
Abstract:
The article analyses the impact of chronobiotics on aging processes and their potential role in geroprotection. Key mechanisms of circadian regulation and their association with age-related diseases, including neurodegenerative and metabolic disorders, are examined. Based on existing scientific data, promising chronobiotics such as melatonin, resveratrol, and their analogs are analysed in terms of their alignment with geroprotector criteria. The main challenges in implementing chronobiotics in clinical practice, including individual chronotypes, genetic factors, and the lack of standardized application protocols, are discussed. In conclusion, promising research directions and recommendations for integrating chronobiotics into healthy aging strategies are proposed.
Insights
Chronobiotics show promise for healthy aging by targeting circadian rhythms linked to age-related diseases. Further research is needed to overcome clinical challenges for effective geroprotection strategies.
Area of Science:
- Chronobiology
- Gerontology
- Pharmacology
Background:
- Aging is associated with disrupted circadian regulation.
- Circadian dysfunction contributes to neurodegenerative and metabolic disorders.
- Chronobiotics modulate biological rhythms.
Purpose of the Study:
- To analyze the impact of chronobiotics on aging processes.
- To evaluate chronobiotics as potential geroprotectors.
- To identify challenges and future directions for chronobiotic use in healthy aging.
Main Methods:
- Review of existing scientific literature on chronobiotics and aging.
- Analysis of key mechanisms in circadian regulation and age-related diseases.
- Assessment of melatonin, resveratrol, and analogs as geroprotectors.
Main Results:
- Chronobiotics, including melatonin and resveratrol, show potential for geroprotection.
- Circadian rhythm mechanisms are linked to aging and related diseases.
- Clinical implementation faces challenges like chronotype variability and lack of standardization.
Conclusions:
- Chronobiotics represent a promising avenue for healthy aging interventions.
- Addressing individual factors and standardizing protocols are crucial for clinical success.
- Further research should focus on optimizing chronobiotic application for geroprotection.
More Related Videos
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
11:003D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells
Published on: October 17, 2025
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
01:19Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...